##analysisDate=2020-02-05-23-41-24-000
##analyzedBy=Ion User
##exportDate=2020-02-06-23-31-23-000
##analysisName=M20-001146_v1_39100eae-d33f-46e7-b850-fc9545bf39da
##workflowName=OCAv3_KRGDB - DNA and Fusions - Single Sample
##sampleNames=M20-001146_v1:M20-001146_RNA_v1
##reference=hg19
##variantGroup=DEFAULT
##filterChain=BRCA_2020
##searchText=
##chromosome=All
##totalVariantCount=2502
##filterInCount=6
##filteredOutCount=2496
##hiddenVariantCount=0
Locus	Genotype	Filter	Ref	Observed Allele	Type	No Call Reason	Genes	Location	Length	Oncomine Variant Class	Oncomine Gene Class	Copy Number	CytoBand	Info	Variant ID	Variant Name	% Frequency	Amino Acid Change	Read Counts	Coverage	Allele Ratio	CNV Confidence	Detection	3'/5' Imbalance	COSMIC/NCBI	Read Counts Per Million	Strand	Exon	Transcript	Coding	Variant Effect	PhyloP	SIFT	Grantham	PolyPhen	PFAM	dbSNP	DGV	MAF	EMAF	AMAF	GMAF	UCSC Common SNPs	ExAC LAF	ExAC EAAF	ExAC OAF	ExAC EFAF	ExAC SAAF	ExAC ENFAF	ExAC AAF	ExAC GAF	Gene Ontology	DrugBank	ClinVar	p-value	Phred QUAL Score	Allele Coverage	CNV Precision	Ref+/Ref-/Var+/Var-	Homopolymer Length	Tiles	Subset of	OCAv3_KRGDB_1100	OCAv3_KRGDB_622
chr13:32890491		PASS		<CNV>	CNV	.	BRCA2		82.441kb			1.68	13q13.1(32890491-32972932)x1.675	HS	BRCA2							5%:1.58, 95%:1.78	Present															esv3306840,esv3329650,esv3426269,esv3580597,nsv1127324,nsv1145657,nsv475474,nsv819799,nsv832576																		100.0					151			
chr13:32911888	A/G	PASS	A	G	SNV		BRCA2	BRCA2:exonic:NM_000059.3	1								66.05	p.(=)		109	A=0.3394, G=0.6606		Present				+	11	NM_000059.3	c.3396A>G	synonymous	0.21				BRCA2 repeat,BRCA2, helical,BRCA2, oligonucleotide/oligosaccharide-binding, domain 1,BRCA2, oligonucleotide/oligosaccharide-binding, domain 3,Tower	rs1060502496,rs1801406		0.267	0.3074	0.2261	0.2798	YES	2.087E-1 (pos.32911888)	3.848E-1 (pos.32911888)	3.149E-1 (pos.32911888)	3.09E-1 (pos.32911888)	2.924E-1 (pos.32911888)	3.064E-1 (pos.32911888)	2.292E-1 (pos.32911888)	2.945E-1 (pos.32911888)	BRCA2-MAGE-D1 complex,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA synthesis involved in DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,brain development,cell aging,centrosome,centrosome duplication,cytokinesis,cytosol,double-strand break repair,double-strand break repair via homologous recombination,establishment of protein localization to telomere,female gonad development,gamma-tubulin binding,hemopoiesis,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,identical protein binding,inner cell mass cell proliferation,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,lateral element,male meiosis I,mitotic recombination-dependent replication fork processing,negative regulation of mammary gland epithelial cell proliferation,nuclear chromosome, telomeric region,nucleoplasm,nucleotide-excision repair,nucleus,oocyte maturation,positive regulation of mitotic cell cycle,positive regulation of transcription, DNA-templated,protease binding,protein C-terminus binding,protein binding,protein complex,regulation of cytokinesis,replication fork protection,response to UV-C,response to X-ray,response to gamma radiation,secretory granule,single-stranded DNA binding,spermatogenesis,strand displacement,telomere maintenance via recombination		Benign	0.00001	834.426	A=37, G=72		A=16/21, G=44/28	4			Ref_Freq=A:0.602273;Alt_Freq=G:0.397727;id=rs1801406	Alt_Freq=0.389068;id=rs1801406
chr13:32915158	C/CG	PASS	C	CG	INDEL		BRCA2	BRCA2:exonic:NM_000059.3	1	Deleterious	Loss-of-function						5.56	p.Phe2223fs		54	C=0.9444, CG=0.0556		Present				+	11	NM_000059.3	c.6666_6667insG	frameshiftInsertion	0.01				BRCA2 repeat,BRCA2, helical,BRCA2, oligonucleotide/oligosaccharide-binding, domain 1,BRCA2, oligonucleotide/oligosaccharide-binding, domain 3,Tower	rs146468642															BRCA2-MAGE-D1 complex,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA synthesis involved in DNA repair,H3 histone acetyltransferase activity,H4 histone acetyltransferase activity,brain development,cell aging,centrosome,centrosome duplication,cytokinesis,cytosol,double-strand break repair,double-strand break repair via homologous recombination,establishment of protein localization to telomere,female gonad development,gamma-tubulin binding,hemopoiesis,histone H3 acetylation,histone H4 acetylation,histone acetyltransferase activity,identical protein binding,inner cell mass cell proliferation,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,lateral element,male meiosis I,mitotic recombination-dependent replication fork processing,negative regulation of mammary gland epithelial cell proliferation,nuclear chromosome, telomeric region,nucleoplasm,nucleotide-excision repair,nucleus,oocyte maturation,positive regulation of mitotic cell cycle,positive regulation of transcription, DNA-templated,protease binding,protein C-terminus binding,protein binding,protein complex,regulation of cytokinesis,replication fork protection,response to UV-C,response to X-ray,response to gamma radiation,secretory granule,single-stranded DNA binding,spermatogenesis,strand displacement,telomere maintenance via recombination			0.09977	10.0098	C=51, CG=3		C=22/29, CG=1/2	0				
chr17:41197602		PASS		<CNV>	CNV	.	BRCA1		78.521kb			1.02	17q21.31(41197602-41276123)x1.025	HS	BRCA1							5%:0.94, 95%:1.11	Present															dgv3175n100,esv2667044,esv2672913,esv2715952,esv33998,esv3640620,nsv1058169,nsv1058376,nsv1059971,nsv1146669,nsv457743,nsv470587,nsv575053,nsv827999,nsv962327																		100.0					107			
chr17:41197670	G/A	PASS	G	A	SNV		BRCA1	BRCA1:utr_3:NM_007300.3	1								6.25	p.?		80	G=0.9375, A=0.0625		Present				-	24	NM_007300.3	c.5680C>T	unknown	2.3				BRCA1 C Terminus (BRCT) domain,RING-type zinc-finger,Ring finger domain,Serine-rich domain associated with BRCT,Zinc finger, C3HC4 type (RING finger),zinc finger of C3HC4-type, RING	rs769632909							0.0 (pos.41197670)	0.0 (pos.41197670)	0.0 (pos.41197670)	0.0 (pos.41197670)	6.16E-5 (pos.41197670)	0.0 (pos.41197670)	0.0 (pos.41197670)	8.359E-6 (pos.41197670)	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA double-strand break processing,DNA recombination,DNA repair,DNA replication,DNA synthesis involved in DNA repair,G2 DNA damage checkpoint,RNA binding,RNA polymerase II transcription coactivator activity,RNA polymerase binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,cell cycle,cellular response to DNA damage stimulus,cellular response to indole-3-methanol,cellular response to tumor necrosis factor,centrosome cycle,chordate embryonic development,chromosome,chromosome segregation,cytoplasm,damaged DNA binding,dosage compensation by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,double-strand break repair via nonhomologous end joining,enzyme binding,fatty acid biosynthetic process,gamma-tubulin ring complex,integral component of membrane,intracellular ribonucleoprotein complex,intrinsic apoptotic signaling pathway in response to DNA damage,lateral element,mitotic G2/M transition checkpoint,negative regulation of G0 to G1 transition,negative regulation of centriole replication,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K4 methylation,negative regulation of histone H3-K9 methylation,negative regulation of histone acetylation,negative regulation of intracellular estrogen receptor signaling pathway,negative regulation of reactive oxygen species metabolic process,negative regulation of transcription, DNA-templated,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of angiogenesis,positive regulation of cell cycle arrest,positive regulation of gene expression,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H3-K9 methylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-templated,positive regulation of vascular endothelial growth factor production,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein deubiquitination,protein ubiquitination,regulation of DNA methylation,regulation of apoptotic process,regulation of cell proliferation,regulation of gene expression by genetic imprinting,regulation of signal transduction by p53 class mediator,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to estrogen,response to ionizing radiation,strand displacement,transcription coactivator activity,transcription regulatory region DNA binding,transcription, DNA-templated,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein transferase activity,zinc ion binding			0.02069	16.8423	G=75, A=5		G=34/41, A=1/4	2				
chr17:41251778	C/T	PASS	C	T	SNV		BRCA1	BRCA1:intronic:NM_007300.3	1								5.08	p.?		59	C=0.9492, T=0.0508		Present				-		NM_007300.3	c.547+14G>A	unknown	-0.64				BRCA1 C Terminus (BRCT) domain,RING-type zinc-finger,Ring finger domain,Serine-rich domain associated with BRCT,Zinc finger, C3HC4 type (RING finger),zinc finger of C3HC4-type, RING	rs273902771,rs932782447							8.637E-5 (pos.41251777)	1.273E-3 (pos.41251777)	0.0 (pos.41251777)	0.0 (pos.41251777)	6.057E-5 (pos.41251777)	2.998E-5 (pos.41251777)	0.0 (pos.41251777)	1.236E-4 (pos.41251777)	BRCA1-A complex,BRCA1-BARD1 complex,DNA binding,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,DNA double-strand break processing,DNA recombination,DNA repair,DNA replication,DNA synthesis involved in DNA repair,G2 DNA damage checkpoint,RNA binding,RNA polymerase II transcription coactivator activity,RNA polymerase binding,androgen receptor binding,androgen receptor signaling pathway,apoptotic process,cell cycle,cellular response to DNA damage stimulus,cellular response to indole-3-methanol,cellular response to tumor necrosis factor,centrosome cycle,chordate embryonic development,chromosome,chromosome segregation,cytoplasm,damaged DNA binding,dosage compensation by inactivation of X chromosome,double-strand break repair,double-strand break repair via homologous recombination,double-strand break repair via nonhomologous end joining,enzyme binding,fatty acid biosynthetic process,gamma-tubulin ring complex,integral component of membrane,intracellular ribonucleoprotein complex,intrinsic apoptotic signaling pathway in response to DNA damage,lateral element,mitotic G2/M transition checkpoint,negative regulation of G0 to G1 transition,negative regulation of centriole replication,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,negative regulation of fatty acid biosynthetic process,negative regulation of histone H3-K4 methylation,negative regulation of histone H3-K9 methylation,negative regulation of histone acetylation,negative regulation of intracellular estrogen receptor signaling pathway,negative regulation of reactive oxygen species metabolic process,negative regulation of transcription, DNA-templated,nucleoplasm,nucleus,plasma membrane,positive regulation of DNA repair,positive regulation of angiogenesis,positive regulation of cell cycle arrest,positive regulation of gene expression,positive regulation of histone H3-K4 methylation,positive regulation of histone H3-K9 acetylation,positive regulation of histone H3-K9 methylation,positive regulation of histone H4-K16 acetylation,positive regulation of histone H4-K20 methylation,positive regulation of histone acetylation,positive regulation of protein ubiquitination,positive regulation of transcription from RNA polymerase II promoter,positive regulation of transcription, DNA-templated,positive regulation of vascular endothelial growth factor production,postreplication repair,protein K6-linked ubiquitination,protein autoubiquitination,protein binding,protein complex,protein deubiquitination,protein ubiquitination,regulation of DNA methylation,regulation of apoptotic process,regulation of cell proliferation,regulation of gene expression by genetic imprinting,regulation of signal transduction by p53 class mediator,regulation of transcription from RNA polymerase II promoter,regulation of transcription from RNA polymerase III promoter,response to estrogen,response to ionizing radiation,strand displacement,transcription coactivator activity,transcription regulatory region DNA binding,transcription, DNA-templated,tubulin binding,ubiquitin ligase complex,ubiquitin protein ligase binding,ubiquitin-protein transferase activity,zinc ion binding		Likely benign	0.07427	11.2918	C=56, T=3		C=28/28, T=2/1	2				
